Clinical Partners has raised new debt facilities
Clinical Partners Ltd. has successfully restructured and upsized its debt facilities to better reflect the scale of the business. The company increased its original US$9.4 million facility, comprising a US$3.4 million term loan and a US$6 million revolving credit facility (RCF), to a US$27 million RCF.
The new facility was secured on improved pricing and with enhanced documentation flexibility, providing additional headroom to support the company’s long-term strategy, including organic and acquisitive growth, as well as indirectly supporting a dividend to shareholders.
Clinical Partners is a leading provider of mental health services, working both privately and with the National Health Service (NHS) to help people of all ages achieve improved mental health outcomes. Through in-person and remote appointments, the company connects thousands of patients with senior clinicians across a broad range of mental health conditions, including autism, attention deficit hyperactivity disorder (ADHD), anxiety and depression.
Oaklins Cavendish, one of Oaklins’ member firms in the UK, advised Clinical Partners in raising new debt facilities. The team supported the company throughout the process, helping to secure a structure aligned with its growth ambitions and long-term strategic objectives.
Sprechen Sie mit dem Deal Team
David Fitzgerald
Oaklins Cavendish
Transaktionen
Rare Patient Voice has been acquired by Konovo
Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.
Mehr erfahrenGSP Group has secured an upsized growth refinancing package from HSBC
The GSP Group has refinanced its growth facilities through an upsized financing package provided by HSBC.
Mehr erfahrenDie Lindenhofgruppe veräussert ihre Mehrheitsbeteiligung an der LabPoint an Affidea Switzerland
Die LabPoint Medizinische Laboratorien AG wurde von Affidea Switzerland AG übernommen. Mit Affidea hat die Lindenhofgruppe AG einen starken strategischen Partner für die Weiterentwicklung der LabPoint gewonnen. Die Lindenhofgruppe bleibt bedeutende Aktionärin und Grosskundin des Unternehmens. Damit schafft sie die Grundlage für eine nachhaltige Weiterentwicklung von LabPoint unter einer neuen Ankeraktionärin. LabPoint soll ihre Position in der Labordiagnostik weiter stärken und gezielt ausbauen.
Mehr erfahren